BioCentury
ARTICLE | Company News

Alliant, Sciele deal

April 30, 2007 7:00 AM UTC

SCRX will acquire Alliant for $122 million in cash and up to $55 million in milestones. SCRX, which develops and markets women’s nutritional supplements and products to treat cardiovascular indication...